RxDoctor Payments DataLook up a doctor →

Ebon Bourne, MD

Internal Medicine · Marietta, GANPI 1225178825

Payments from drug & device makers

$242,327in general payments, 2019–2025

Across 1,222 payments — averaging $198.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$226K
  • Eli Lilly$4K
  • Amgen$2K
  • Amarin Pharma, Inc.$1K
  • Novo Nordisk$1K
  • AbbVie$1K
  • plus $8K from 45 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC580$225,778
Eli Lilly2$3,750
Amgen87$1,532
Amarin Pharma, Inc.34$1,324
Novo Nordisk91$1,246
AbbVie(2 entities)73$1,196
Pfizer37$1,053
Sanofi-aventis U.S. LLC30$646
Takeda Pharmaceuticals U.S.A., Inc.35$644
Astellas Pharma US Inc23$537
AstraZeneca33$530
Abbott10$444
Boehringer Ingelheim21$372
Johnson & Johnson13$317
Merck18$286
GSK17$279
Dexcom, Inc.9$265
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$236
Novartis11$225
Exact Sciences12$221
Heartflow, Inc.7$186
Esperion Therapeutics, Inc.7$123
Idorsia Pharmaceuticals US Inc6$106
Inspire Medical Systems, Inc.2$92
Xeris Pharmaceuticals, Inc.4$82
Dynavax Technologies Corporation3$79
Biohaven Pharmaceutical Holding Company Ltd.4$77
Antares Pharma, Inc.5$72
Bayer4$67
Corcept Therapeutics2$60
Biohaven Pharmaceuticals, Inc.3$50
Kowa Pharmaceuticals America, Inc.3$42
Boston Scientific1$34
Nalpropion Pharmaceuticals LLC2$33
Currax Pharmaceuticals LLC2$30
Eisai Inc.2$30
Jazz Pharmaceuticals Inc.1$29
Supernus Pharmaceuticals, Inc.1$25
Vital Connect, Inc1$24
Integra Lifesciences Corporation1$24
Philips North America LLC1$20
Teva Pharmaceuticals USA, Inc.1$19
Bausch Health US, LLC1$19
Nevro Corp.1$18
Insulet Corporation1$16
Watermark Medical, Inc.1$16
Radius Health, Inc.1$16
Sumitomo Pharma America, Inc.1$16
Shire North American Group Inc1$15
Sunovion Pharmaceuticals Inc.1$13
Gilead1$12

How this compares

$242,327 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia →

Medicare billing

Part B allowed, 2024
$104,112
Medicare patients
427
Services billed
1,122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Marietta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →